NCT02631746 2025-03-14
Nivolumab in Treating Patients With HTLV-Associated T-Cell Leukemia/Lymphoma
National Cancer Institute (NCI)
Phase 2 Completed
Clinical Trials
4 trialsNCT03226119 2018-09-13
MP Diagnostics HTLV Blot 2.4 Post-Market Clinical Study
MP Biomedicals, LLC
Phase 4 Completed
NCT00001156 2017-07-02
Assessment of Patients With Multiple Sclerosis (MS)
National Institutes of Health Clinical Center (CC)
Completed
NCT03146013 2017-06-12
Dual Algorithm Post Market Clinical Study
MP Biomedicals, LLC
Completed